Company overview
Inscripta provides the Onyx benchtop platform for scalable CRISPR-based digital genome engineering, enabling massively parallel editing of single cells with automated workflows, consumables, software, and assays. The company also offers GenoScaler, a microbial strain engineering platform using CRISPR, AI, and machine learning for biomanufacturing applications in pharmaceuticals, agriculture, and chemicals. Headquartered in Boulder, Colorado, with offices in California and Denmark, Inscripta supports global research labs in accelerating biological discovery and strain optimization.
Inscripta is now Manus is listed in the NovaPharmaNews Supplier Hub as a CRO & Clinical Services, CDMO & Manufacturing partner serving United States & Americas. Core focus areas include genome engineering, crispr platform, onyx platform, genoscaler, biomanufacturing, microbial strain engineering.
Industry categories: CRO & Clinical Services, CDMO & Manufacturing. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Products and technologies associated with Inscripta is now Manus include Cro — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://www.inscripta.com
- Categories
- CRO & Clinical Services, CDMO & Manufacturing
- Markets served
- United States & Americas
- Keywords
- genome engineering, crispr platform, onyx platform, genoscaler, biomanufacturing, microbial strain engineering
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What genome engineering platforms does Inscripta offer?
- Inscripta offers the Onyx benchtop system for automated CRISPR-based editing and GenoScaler for high-throughput microbial strain engineering using CRISPR, AI, and machine learning.
- What industries does Inscripta serve?
- Inscripta serves pharmaceuticals, agriculture, chemicals, personal care, and biomanufacturing for sustainable ingredient production.
- Where are Inscripta's facilities located?
- Inscripta has facilities in Boulder, Colorado; San Diego and Pleasanton, California; and Copenhagen, Denmark, supporting global customers.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.